As of mid-August 2026, CDC data show 2,777 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289—with 36 new outbreaks and 94% of cases linked to sustained transmission clusters. Primary drivers include persistently low MMR vaccination rates in specific communities, allowing the highly contagious virus (basic reproduction number 12–18) to spread rapidly among unvaccinated children and young adults. Most cases involve individuals with zero or incomplete vaccination, consistent with historical patterns where coverage below 95% enables endemic circulation. Weekly CDC surveillance updates, state-level reporting on new outbreaks, and any shifts in MMR uptake will directly influence trader assessments of whether 2026 totals remain elevated or begin to decline.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,848,056 Wol.
$7,848,056 Wol.
Dec 30, 2026
↑4.5k
57%
↑3k
99%
↑3.5k
95%
↑4k
83%
↑5k
48%
↑7,5 tys.
12%
↑10k
6%
↑12,5 tys.
6%
$7,848,056 Wol.
$7,848,056 Wol.
Dec 30, 2026
↑4.5k
$28 Wol.
57%
↑3k
$91,396 Wol.
99%
↑3.5k
$14,126 Wol.
95%
↑4k
$231,411 Wol.
83%
↑5k
$232,526 Wol.
48%
↑7,5 tys.
$185,371 Wol.
12%
↑10k
$6,516,697 Wol.
6%
↑12,5 tys.
$350,733 Wol.
6%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC data show 2,777 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289—with 36 new outbreaks and 94% of cases linked to sustained transmission clusters. Primary drivers include persistently low MMR vaccination rates in specific communities, allowing the highly contagious virus (basic reproduction number 12–18) to spread rapidly among unvaccinated children and young adults. Most cases involve individuals with zero or incomplete vaccination, consistent with historical patterns where coverage below 95% enables endemic circulation. Weekly CDC surveillance updates, state-level reporting on new outbreaks, and any shifts in MMR uptake will directly influence trader assessments of whether 2026 totals remain elevated or begin to decline.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Feb 16, 2026, 11:51 AM ET
Wolumen
$7,848,056Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC data show 2,777 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289—with 36 new outbreaks and 94% of cases linked to sustained transmission clusters. Primary drivers include persistently low MMR vaccination rates in specific communities, allowing the highly contagious virus (basic reproduction number 12–18) to spread rapidly among unvaccinated children and young adults. Most cases involve individuals with zero or incomplete vaccination, consistent with historical patterns where coverage below 95% enables endemic circulation. Weekly CDC surveillance updates, state-level reporting on new outbreaks, and any shifts in MMR uptake will directly influence trader assessments of whether 2026 totals remain elevated or begin to decline.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,848,056Data zakończenia
Dec 31, 2026Rynek otwarty
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, CDC data show 2,777 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289—with 36 new outbreaks and 94% of cases linked to sustained transmission clusters. Primary drivers include persistently low MMR vaccination rates in specific communities, allowing the highly contagious virus (basic reproduction number 12–18) to spread rapidly among unvaccinated children and young adults. Most cases involve individuals with zero or incomplete vaccination, consistent with historical patterns where coverage below 95% enables endemic circulation. Weekly CDC surveillance updates, state-level reporting on new outbreaks, and any shifts in MMR uptake will directly influence trader assessments of whether 2026 totals remain elevated or begin to decline.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania